Figure 1.
The dose-response curves determined using the MTT assay of the hematopoietic stem and progenitor cells (HSPCs) treated for 24 h with gemcitabine in log10(ng/mL) and carboplatin in log10(µg/mL). The error bars denote the standard deviation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.